CBD has solid evidence for rare pediatric epilepsies, preliminary signal in anxiety and psychosis, and insufficient evidence for most conditions it’s marketed for.
Global age-standardized substance-use-disorder rates fell 16.9% from 1990–2021. High-income North America rose 24%—the divergence US coverage misses.
Alcohol’s effects on the brain, especially among the elderly, have long been a subject of scientific inquiry. A recent study from Gothenburg, Sweden, provides new insights into how varying levels of alcohol consumption impact brain structure in individuals aged 70 and over. This research sheds light on the relationship between alcohol intake and the aging …
Parkinson’s disease (PD), a degenerative disorder that predominantly affects the motor system, has long been a challenging condition to manage due to its complex pathology and the limited efficacy of available treatments. However, recent research presents a beacon of hope through a novel combined therapy targeting the core of Parkinson’s disease’s neuronal degradation. This innovative …
The opioid crisis, particularly in North America, has spotlighted oxycodone as a central figure due to its significant role in addiction and overdose deaths. A recent review analyzed the genomic and epigenetic mechanisms behind oxycodone’s effects compared to other opioids, shedding light on its unique impact on addiction pathways. Highlights: Oxycodone, a semi-synthetic opioid derived …
Fentanyl, a synthetic opioid exponentially stronger than morphine, has transitioned from an unwanted contaminant in the illicit drug market to a sought-after substance among people who use drugs (PWUD). This shift underscores a critical change in drug use patterns, motivations, and the associated demographic and socioeconomic factors contributing to its rising preference. Highlights: Fentanyl’s Potency: …
Tramadol, commonly known for its pain-relieving properties, has emerged as an effective off-label treatment for depression according to patient experiences and reviews. A recent analysis of tramadol’s antidepressant potential examined user feedback – comparing its efficacy and safety with established antidepressants. It considered the perspectives of patients who have found relief from depression with tramadol, …